Literature DB >> 19399358

Heritability of Trail Making Test performance in multiplex schizophrenia families: implications for the search for an endophenotype.

Raúl Mendoza Quiñones1, Yuranny Cabral Calderín, Mayelin Domínguez, Tania M Bravo, Adnelys Reyes Berazaín, Alexander García, Antonio Caballero, Migdyrai Martín Reyes.   

Abstract

The impairment of the Trail Making Test (TMT) performance as a measure of executive function deficits has been found both in patients with schizophrenia and in their unaffected first-degree relatives, suggesting that it might be considered as a familial vulnerability marker, but its heritability estimates are not well known. This study investigated the genetic heritability of impairments in TMT performance using a sample of 80 schizophrenia patients, 145 unaffected first-degree relatives and 127 healthy controls from families with multiple members with schizophrenia. Consistent with previous reports in the literature, relatives performed in between healthy controls and schizophrenia patients. Based on these results, a variance component-analysis provided small, but significant additive heritability estimates for performance indices relating performance in TMT-version A to TMT-version B. These results showed that this significant but small evidence of heritability on the one hand suggests an association with genetic predisposition to schizophrenia, but that TMT performance is also associated with epigenetic or environmental factors.

Entities:  

Mesh:

Year:  2009        PMID: 19399358     DOI: 10.1007/s00406-009-0012-6

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  35 in total

1.  Trail making test, part B as a measure of executive control: validation using a set-switching paradigm.

Authors:  K Arbuthnott; J Frank
Journal:  J Clin Exp Neuropsychol       Date:  2000-08       Impact factor: 2.475

2.  Heritability of Wisconsin Card Sorting Test (WCST) and Stroop Color-Word Test performance in normal individuals: implications for the search for endophenotypes.

Authors:  Jeanette Taylor
Journal:  Twin Res Hum Genet       Date:  2007-12       Impact factor: 1.587

3.  Neurocognitive impairments in nonpsychotic parents of children with schizophrenia and attention-deficit/hyperactivity disorder: the University of California, Los Angeles Family Study.

Authors:  Robert F Asarnow; Keith H Nuechterlein; Kenneth L Subotnik; David L Fogelson; Richard D Torquato; Diana L Payne; Joy Asamen; Jim Mintz; Donald Guthrie
Journal:  Arch Gen Psychiatry       Date:  2002-11

4.  Tests of executive functions in first-degree relatives of schizophrenic patients: a meta-analysis.

Authors:  Andrei Szöke; Franck Schürhoff; Flavie Mathieu; Alexandre Meary; Serban Ionescu; Marion Leboyer
Journal:  Psychol Med       Date:  2005-06       Impact factor: 7.723

5.  Cognitive functioning in the early course of first-episode schizophrenia spectrum disorders: timing and patterns.

Authors:  César González-Blanch; Mario Alvarez-Jiménez; José Manuel Rodríguez-Sánchez; Rocío Pérez-Iglesias; José Luis Vázquez-Barquero; Benedicto Crespo-Facorro
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-06-20       Impact factor: 5.270

6.  Impairments of executive/attentional functions in schizophrenia with primary and secondary negative symptoms.

Authors:  Perrine Brazo; Pascal Delamillieure; Rémy Morello; Isabelle Halbecq; Rose-Marie Marié; Sonia Dollfus
Journal:  Psychiatry Res       Date:  2005-01-30       Impact factor: 3.222

7.  Finding suitable phenotypes for genetic studies of schizophrenia: heritability and segregation analysis.

Authors:  Maartje F Aukes; Behrooz Z Alizadeh; Margriet M Sitskoorn; Jean-Paul Selten; Richard J Sinke; Chantal Kemner; Roel A Ophoff; René S Kahn
Journal:  Biol Psychiatry       Date:  2008-03-04       Impact factor: 13.382

8.  Executive dysfunctions as potential markers of familial vulnerability to bipolar disorder and schizophrenia.

Authors:  Tiziana Zalla; Cécile Joyce; Andrei Szöke; Franck Schürhoff; Bernard Pillon; Odile Komano; Fernando Perez-Diaz; Frank Bellivier; Caroline Alter; Bruno Dubois; Frédéric Rouillon; Olivier Houde; Marion Leboyer
Journal:  Psychiatry Res       Date:  2004-01-01       Impact factor: 3.222

9.  Cognitive deficits in relatives of patients with schizophrenia: a meta-analysis.

Authors:  Margriet M Sitskoorn; André Aleman; Sjoerd J H Ebisch; Melanie C M Appels; René S Kahn
Journal:  Schizophr Res       Date:  2004-12-01       Impact factor: 4.939

10.  Effects of risperidone and quetiapine on cognition in patients with schizophrenia and predominantly negative symptoms.

Authors:  Michael Riedel; Ilja Spellmann; Martin Strassnig; Anette Douhet; Sandra Dehning; Markus Opgen-Rhein; Rosamaria Valdevit; Rolf R Engel; Nikolaus Kleindienst; Norbert Müller; Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-07-14       Impact factor: 5.270

View more
  3 in total

1.  Longitudinal alterations of executive function in non-psychotic adolescents at familial risk for schizophrenia.

Authors:  Tejas S Bhojraj; Vaibhav A Diwadkar; John A Sweeney; Konasale M Prasad; Shaun M Eack; Debra M Montrose; Matcheri S Keshavan
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2010-01-29       Impact factor: 5.067

2.  Prefrontal deviations in function but not volume are putative endophenotypes for schizophrenia.

Authors:  Sheena F Owens; Marco M Picchioni; Ulrich Ettinger; Colm McDonald; Muriel Walshe; Anne Schmechtig; Robin M Murray; Fruhling Rijsdijk; Timothea Toulopoulou
Journal:  Brain       Date:  2012-06-12       Impact factor: 13.501

3.  Dopaminergic gene polymorphisms and cognitive function in a north Indian schizophrenia cohort.

Authors:  Prachi Kukshal; Venkat Chowdari Kodavali; Vibhuti Srivastava; Joel Wood; Lora McClain; Triptish Bhatia; A M Bhagwat; Smita Neelkanth Deshpande; Vishwajit Laxmikant Nimgaonkar; B K Thelma
Journal:  J Psychiatr Res       Date:  2013-08-08       Impact factor: 4.791

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.